Author(s): K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma

Email(s): ruchi.verma@manipal.edu , ruchiverma_farma@yahoo.com

DOI: 10.52711/0974-360X.2021.01026   

Address: K Poojita1, Fajeelath Fathima1, Rajdeep Ray1, Lalit Kumar2, Ruchi Verma1*
1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal academy of Higher Education, Madhav Nagar-576104, Manipal, Udupi, Karanataka, India.
2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal academy of Higher Education, Madhav Nagar-576104, Manipal, Udupi, Karanataka, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 11,     Year - 2021


ABSTRACT:
Tuberculosis disease is world’s biggest threat to health with a high mortality rate. There has been a steady surge in the frequency of MDR-TB and XDR-TB. Hence, it is imperative to encourage the research and development of novel drugs to counteract the infection. Decaprenylphosphoryl-ß-D-ribose-2'a-epimerase 1 (DprE1) is a valuable enzyme which is responsible for the stability and virulence of the infection causing bacteria (Mycobacterium tuberculosis) thereby making it a perfect target for drugs anti TB activity. This study represent atom based 3D QSAR model consisting the derivatives of DprE1 inhibitors and provides guidance and insight to develop and identify new novel molecule which have good therapeutic efficiency as Anti TB drugs.


Cite this article:
K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. 3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents. Research Journal of Pharmacy and Technology. 2021; 14(11):5903-0. doi: 10.52711/0974-360X.2021.01026

Cite(Electronic):
K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. 3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents. Research Journal of Pharmacy and Technology. 2021; 14(11):5903-0. doi: 10.52711/0974-360X.2021.01026   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-52


REFERENCES:
1.    World Health Organisation. Global Tuberculosis Report 2019. Accessed on January 2020.
2.    Singh S, Kumar S. Tuberculosis in India: Road to elimination. Int J Prev Med 2019; 10:114.
3.    Chikhale, Rupesh V et al. “Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis.” Journal of Medicinal Chemistry vol. 61,19 (2018)
4.    Makarov V, Neres J, Hartkoorn RC, et al. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2015;59 (8):4446-4452.
5.    R MM, Shandil R, Panda M, et al. Scaffold Morphing to Identify Novel DprE1 Inhibitors with Antimycobacterial Activity. ACS Med Chem Lett. 2019; 10 (10):1480-1485. Published 2019
6.    Kumar L, Verma R. Molecular docking-based approach for the design of novel flavone analogues as inhibitor of beta-hydroxyacyl-ACP dehydratase HadAB complex. Research J. of Pharm. and tech. 10(8); 2439-2445.
7.    Lohit T, Kumar L, Verma R. Design, Molecular Docking, ADME Analysis and Molecular Dynamics Studies of Novel Acetylated Schiff bases as COX-2 inhibitors. Research J. Pharm. and Tech. 13(4); 1901-1906.
8.    Prem SM, Ravichandiran V, Aanandhi MV. Design, Synthesis and in silico molecular docking study of N-carbamoyl-6-oxo-1-phenyl-1, 6-dihydropyridine-3-carboxamide derivatives as fibroblast growth factor 1 inhibitor. Research Journal of Pharmacy and Technology. 10(8); 2017:2527-2534.
9.    Habeela JN, Raja MKMM. In silico molecular docking studies on the chemical constituents of clerodendrum phlomidis for its cytotoxic potential against breast cancer markers. Research Journal of Pharmacy and Technology. 11 (4); 1612-1618:2018.
10.    Surakanti R, Eppakayala L, Ramchander M, Venkat RP. Synthesis and molecular docking for anti-inflammatory and anti-mitotic activities of (S)-(2-Methyl-4-(1-Phenyl-1h-Thieno/Furan [3, 2-C] Pyrazol-3-yl) Piperazin-1-yl) (Pyridin-2-yl) Methanone. Asian Journal of Research in Chemistry. 10(4); 2017:582-586.
11.    Hemalatha K, Chakkaravarthi V, Ganesa Murthy K, Kayatri R, Girija K. Molecular Properties and Docking Studies of Benzimidazole Derivatives as Potential Peptide Deformylase Inhibitors. Asian Journal of Research in Chemistry. 7(7); 2014: 644-648.
12.    Ul-Haq Z, Effendi JS, Ashraf S, Bkhaitan MM. Atom and receptor-based 3D QSAR models for generating new conformations from pyrazolopyrimidine as IL-2 inducible tyrosine kinase inhibitors. J Mol Graph Model. 2017; 74: 379‐395.
13.    Wang M, Li W, Wang Y, Song Y, Wang J, Cheng M. In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery. J Mol Graph Model. 2018; 84:18‐28.
14.    Kristam R, Parmar V, Viswanadhan VN. 3D-QSAR analysis of TRPV1 inhibitors reveals a pharmacophore applicable to diverse scaffolds and clinical candidates. J Mol Graph Model. 2013; 45: 157‐172.
15.    Ruchi V, Indira B, Mradul T, Varadaraj BG· Gautham GS. In silico studies, synthesis and anticancer activity of novel diphenyl ether-based pyridine derivatives. Molecular Diversity. 23; 2019: 541–554.
16.    Prem SM, Ravichandiran V, Aanandhi MV. Design, Synthesis and in silico molecular docking study of N-carbamoyl-6-oxo-1-phenyl-1, 6-dihydropyridine-3-carboxamide derivatives as fibroblast growth factor 1 inhibitor. Research Journal of Pharmacy and Technology. 10(8); 2017:2527-2534.
17.    Ganatra S. H., Patle M. R, Bhagat G. K. Studies of Quantitative Structure-Activity Relationship (QSAR) of Hydantoin Based Active Anti-Cancer Drugs. Asian J. Research Chem. 2011; 4(10): 1643-1648.
18.    R. S. Kalkotwar, R. B. Saudagar. Synthesis and QSAR Studies of Some 2,5-Diaryl Substituted-1,3,4-Oxadiazole Derivatives. Asian J. Research Chem. 2013, (11): 985-991.
19.    V. S. Kawade, S. S. Kumbhar, P. B. Choudhari, M. S. Bhatia. 3D QSAR and Pharmacophore Modelling of some Pyrimidine Analogs as CDK4 Inhibitors. Asian J. Research Chem 2015; 8(4): 231-235.
20.    Lohith T N1, Lalit Kumar2, Ruchi Verma Design, Molecular Docking, ADME Analysis and Molecular Dynamics Studies of Novel Acetylated Schiff bases as COX-2 inhibitors. Research J. Pharm. and Tech. 2020; 13(4):1901-1906

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available